You are here

Updates

The annual meeting of the Health Ministers from the Group of 7 (G7) countries took place from September 11-12, 2016, in Kobe, Japan. The Sabin Vaccine Institute (Sabin) was pleased to see the G7 Health Ministers Kobe Communiqué reiterate a continued emphasis on strengthening efforts to control infectious diseases through international cooperation. As the Health Ministers concluded, “Health is the foundation of human security…We are determined to commit to a healthier world, where all people can receive the basic quality services they need, and are protected from public health threats.”

WASHINGTON, D.C. — June 22, 2016 — The Sabin Vaccine Institute is partnering with King Saud University (KSU) in Riyadh, Saudi Arabia, to advance vaccine research and development capacity in the Middle East and North Africa. As part of the new $6.6 million agreement, Saudi scientists will receive technical training in vaccine development at the Sabin Vaccine Institute Product Development Partnership (Sabin PDP) laboratories in Houston, Texas.

Statement of Dr. Peter Hotez, President of the Sabin Vaccine Institute and Director of its Product Development Partnership on the Group of 7 (G7) Summit, at which the leaders of Japan, the United States, the United Kingdom, Germany, Canada, Italy and France affirmed a commitment to neglected tropical diseases (NTDs).

by Peter Hotez, M.D., Ph.D. Hotez is Dean of the National School of Tropical Medicine at Baylor College of Medicine where he is also the Texas Children’s Hospital Endowed Chair in Tropical Pediatrics and the University Professor of Biology at Baylor University.